19-18913025-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_007263.4(COPE):c.148G>T(p.Val50Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,459,518 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_007263.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COPE | NM_007263.4 | c.148G>T | p.Val50Leu | missense_variant | 2/10 | ENST00000262812.9 | NP_009194.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COPE | ENST00000262812.9 | c.148G>T | p.Val50Leu | missense_variant | 2/10 | 1 | NM_007263.4 | ENSP00000262812.3 | ||
ENSG00000268193 | ENST00000596918.5 | n.*189G>T | non_coding_transcript_exon_variant | 5/7 | 5 | ENSP00000469669.1 | ||||
ENSG00000268193 | ENST00000596918.5 | n.*189G>T | 3_prime_UTR_variant | 5/7 | 5 | ENSP00000469669.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1459518Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 726206
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 28, 2023 | The c.148G>T (p.V50L) alteration is located in exon 2 (coding exon 2) of the COPE gene. This alteration results from a G to T substitution at nucleotide position 148, causing the valine (V) at amino acid position 50 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.